Date: 2013-12-06
Type of information:
phase:
Announcement:
Company: Nanobiotix (France)
Product: NBTX-TOPO
Action
mechanism: The NBTX-TOPO product is a gel containing nanoparticles which is designed for direct application to the « tumor bed », the cavity left following the surgical removal of a tumor. This product could form part of the standard procedure to prepare a site for post-operative radiotherapy to destroy residual cancer cells.
Disease:
Therapeutic area: Cancer - Oncology
Country:
Trial details:
Latest
news: * On December 6, 2013, Nanobiotix, a clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, has announced, in accordance with its plans, the selection of its new product, NBTX-TOPO, in view of its preclinical development.Third product from the NanoXray platform, this product combines two important functions: a more efficient eradication of remaining cancer cells following the surgical removal of a tumor and a more accurate localization of a tumor. NBTX-TOPO is potentially applicable for all types of post-operative radiotherapy.This is the third product from the NanoXray technology platform to be developed which is a major milestone achievement.
